BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9805748)

  • 1. [Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography].
    Vaylet F; Foehrenbach H; De Dreuille O; Maszelin P; Merlet P; Bendriem B; L'Her P; Syrota A; Gaillard JF
    Rev Pneumol Clin; 1998 Sep; 54(4):187-95. PubMed ID: 9805748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Gupta NC; Frank AR; Dewan NA; Redepenning LS; Rothberg ML; Mailliard JA; Phalen JJ; Sunderland JJ; Frick MP
    Radiology; 1992 Aug; 184(2):441-4. PubMed ID: 1620844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of pulmonary lesions with positron emission tomography].
    Knopp MV; Bischoff HG
    Radiologe; 1994 Oct; 34(10):588-91. PubMed ID: 7816916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
    Gupta NC; Maloof J; Gunel E
    J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchogenic carcinoma associated with rheumatoid arthritis: role of FDG-PET scans.
    Rodríguez P; Romero T; Rodríguez de Castro F; Hussein M; Freixinet J
    Rheumatology (Oxford); 2006 Mar; 45(3):359-60. PubMed ID: 16436491
    [No Abstract]   [Full Text] [Related]  

  • 9. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
    Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
    AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of 18F-FDG positron emission tomography in surgical evaluation].
    Franzius C; Sciuk J; Schober O
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():261-9. PubMed ID: 9931622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.
    Mori T; Nomori H; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Oncol; 2008 Apr; 3(4):358-64. PubMed ID: 18379353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to clinical positron emission tomography.
    Agress H
    N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positron emission tomography of the thorax. The current clinical status].
    Knopp MV; Bischoff H; Oberdorfer F; van Kaick G
    Radiologe; 1992 Jun; 32(6):290-5. PubMed ID: 1641486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
    Worsley DF; Celler A; Adam MJ; Kwong JS; Müller NL; Coupland DB; Champion P; Finley RJ; Evans KG; Lyster DM
    AJR Am J Roentgenol; 1997 Mar; 168(3):771-4. PubMed ID: 9057532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
    Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
    AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiologic diagnosis of bronchogenic carcinoma].
    Dalagija F
    Med Arh; 1995; 49(3-4 Suppl 1):37-41. PubMed ID: 9623065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.